Risperidone long-acting injection (RLAI)-related sexual dysfunction in outpatients with schizophrenia

被引：0
|
作者：
Grosic, V.
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] Descriptive study about long-acting injectable risperidone (RLAI) in outpatients
    Sala Cassola, R.
    Sobrino Cabra, O.
    Moreno Menguiano, C.
    EUROPEAN PSYCHIATRY, 2007, 22 : S165 - S166
  • [2] The use of risperidone long-acting injection (RLAI) in a high secure hospital
    Gibbon, S. D.
    Gahir, M.
    Huckstep, B.
    EUROPEAN PSYCHIATRY, 2007, 22 : S308 - S308
  • [3] NATURALISTIC OBSERVATIONAL STUDY OF PATIENTS RECEIVING RISPERIDONE LONG-ACTING INJECTION (RLAI)
    Gupta, N.
    Riley, C.
    Agell, I.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [4] COMPARING risperidone long-acting injection (RLAI) with oral antipsychotics in Spanish patients with schizophrenia using propensity scoring
    Diels, J.
    Olivares, J. M.
    Rodriguez-Morales, A.
    Caleo, S.
    EUROPEAN PSYCHIATRY, 2007, 22 : S110 - S111
  • [5] Improvements in illness severity and functioning in Australian schizophrenia patients treated with risperidone long-acting injection (RLAI) for 12 months
    Hustig, H.
    Lambert, T.
    Emmerson, B.
    Povey, M.
    Jacobs, A.
    Methven, C.
    EUROPEAN PSYCHIATRY, 2007, 22 : S117 - S117
  • [6] Long-acting risperidone injection
    Love, RC
    Conley, RJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (17) : 1792 - 1800
  • [7] Improvements in illness severity and functioning in schizophrenic patients switched to risperidone long-acting injection (RLAI)
    Peuskens, J.
    Povey, M.
    Diels, J.
    Van der Veken, J.
    Jacobs, A.
    VALUE IN HEALTH, 2006, 9 (06) : A320 - A320
  • [8] Substance abuse (SA) does not compromise significant improvements in Spanish patients with schizophrenia treated with risperidone long-acting injection (RLAI)
    Olivares, J. M.
    Rodriguez, A.
    Buron, J. A.
    Rodriguez-Morales, A.
    Povey, M.
    Jacobs, A.
    EUROPEAN PSYCHIATRY, 2007, 22 : S117 - S117
  • [9] EFFICACY AND TOLERABILITY AMONG PATIENTS WITH RECENT ONSET SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG-ACTING INJECTABLE (RLAI)
    Napryeyenko, Oleksandr
    Burba, Benjaminas
    Martinez, Guadalupe
    Neznanov, Nikolay
    Fischel, Tsvi
    Bayle, Franck
    Corrivetti, Giulio
    Smeraldi, Enrico
    Rabinowitz, Jonathan
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 496 - 496
  • [10] COLLABORATIVE STUDY OF COMPLIANCE IN PSYCHOTIC PATIENTS WITH RISPERIDONE LONG-ACTING INJECTION (RLAI) IN THE LAST 5 YEARS
    Molina Ramos, R.
    Arnillas, H.
    Playa, J.
    Sanchez de Muniain, M.
    LLiteras, M.
    Hernandez, B.
    EUROPEAN PSYCHIATRY, 2011, 26
12345